Reclassification of CLSI criteria for ciprofloxacin and levofloxacin susceptibility against Pseudomonas aeruginosa: Implications for patients with cystic fibrosis (CF)

被引：1
|
作者：
Millar, Beverley Cherie [1 ,2 ,3 ]
Malnarcic, Camila M. [1 ,4 ]
McCaughan, John [5 ]
Moore, John E. [1 ,2 ,3 ]
机构：
[1] Belfast City Hosp, Dept Bacteriol, Northern Ireland Publ Hlth Lab, Belfast BT9 7AD, Antrim, North Ireland
[2] Queens Univ, Wellcome Wolfson Inst Expt Med, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland
[3] Univ Ulster, Sch Biomed Sci, Coleraine, Londonderry, North Ireland
[4] Fac Med Faceres, Sao Jose Do Rio Preto, Brazil
[5] Royal Grp Hosp, Dept Med Microbiol, Belfast, Antrim, North Ireland
来源：
CLINICAL RESPIRATORY JOURNAL | 2020年 / 14卷 / 01期
关键词：
D O I：
10.1111/crj.13100
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：64 / 68
页数：5
相关论文
共 50 条
  • [1] Susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients to ciprofloxacin
    Bauernfeind, A
    Jungwirth, R
    Ratjen, F
    DRUGS, 1999, 58 (Suppl 2) : 209 - 210
  • [2] Susceptibility of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients to Ciprofloxacin
    A. Bauernfeind
    R. Jungwirth
    F. Ratjen
    Drugs, 1999, 58 : 209 - 210
  • [3] Occurrence of Pseudomonas aeruginosa in waters: implications for patients with cystic fibrosis (CF)
    Caskey, S.
    Stirling, J.
    Moore, J. E.
    Rendall, J. C.
    LETTERS IN APPLIED MICROBIOLOGY, 2018, 66 (06) : 537 - 541
  • [4] Is levofloxacin as active as ciprofloxacin against Pseudomonas aeruginosa?
    Bonfiglio, G
    CHEMOTHERAPY, 2001, 47 (04) : 239 - 242
  • [5] THE TREATMENT EFFECT OF CIPROFLOXACIN ON PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS PATIENTS
    Dalboge, C. S.
    Nielsen, X. C.
    Dalhoff, K.
    Duno, M.
    Buchard, A.
    Jensen, A. G.
    Pressler, T.
    Hengzhuang, W.
    Hoiby, N.
    Johansen, H. K.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 339 - 339
  • [6] STUDIES ON THE EFFECTS OF CIPROFLOXACIN ON PSEUDOMONAS AERUGINOSA EVOLUTION IN CYSTIC FIBROSIS PATIENTS
    Jorth, P.
    Hisert, K. B.
    Garudathri, J.
    Wolter, D.
    Hoffman, L.
    Singh, P.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 349 - 349
  • [7] Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients
    Rao, Priyanka
    McCaughan, John
    McCalmont, Mark
    Goldsmith, Colin E.
    Hall, Valerie
    Millar, B. Cherie
    McCann, Mary-Ann
    Downey, Damian G.
    Rendall, Jacqueline C.
    Elborn, J. Stuart
    Moore, John E.
    JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (04) : 349 - 352
  • [8] Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis
    Stockmann, Chris
    Sherwin, Catherine M. T.
    Ampofo, Krow
    Spigarelli, Michael G.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2014, 8 (01) : 13 - 21
  • [9] PSEUDOMONAS-AERUGINOSA ALLERGY IN PATIENTS WITH CYSTIC-FIBROSIS (CF)
    STAHLSKOV, P
    SCHIOTZ, PO
    PERMIN, H
    HOIBY, N
    NORN, S
    ALLERGY, 1978, 33 (06) : 339 - 340
  • [10] Susceptibility of Pseudomonas aeruginosa to Levofloxacin and Trovafloxacin Based on MICs for Ciprofloxacin and Ofloxacin
    Ken B. Waites
    Drugs, 1999, 58 : 211 - 213
12345